Skip to main content

Table 1 Association of NMI expression with patients’ clinicopathological features in human lung adenocarcinoma (n = 75)

From: Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas

  Total adenocarcinoma (N = 75) NMI low expression (N = 43) NMI high expression (N = 43) p
Gender
 Male 39 20 (51.3%) 19 (48.7%) 0.351
 Female 36 23 (63.9%) 13 (36.1%)  
Age at diagnosis
 < 60 43 24 (55.8%) 19 (44.2%) 0.816
 ≥ 60 32 19 (59.4%) 13 (40.6)  
pT factor
 T1 21 9 (42.9%) 12 (57.1%) 0.443
 T2 42 25 (59.5%) 17 (40.5%)  
 T3 + T4 12 6 (50%) 6 (50%)  
pN factor
 N0 + N1 52 28 (53.8%) 24 (46.2%) 0.4513
 N2 + N3 + NX 23 15 (65.2%) 8 (34.8%)